Journal of Liver

Impact of Hepatic Steatosis During Alcohol Consumption

Kyung Hoon^* Department of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
^*Correspondence: Kyung Hoon, Department of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria, Email:

Received: 02-May-2023, Manuscript No. JLR-23-21834; Editor assigned: 05-May-2023, Pre QC No. JLR-23-21834(PQ); Reviewed: 19-May-2023, QC No. JLR-23-21834; Revised: 26-May-2023, Manuscript No. JLR-23-21834(R); Published: 02-Jun-2023, DOI: 10.35248/2167-0889.23.12.184

Description

Alcohol is one of the leading causes of liver damage when the liver damage is occured due to overtaking of alcohol it’s called as alcohol-related liver disease. Alcohol-related liver disease actually encompasses three different liver conditions: Alcoholic fatty liver disease, alcoholic hepatitis, and alcoholic cirrhosis. These conditions can impair the liver’s ability to carry out its vital functions, such as breaking down toxins, producing bile, storing nutrients, and making proteins [1,2]. Hepatic steatosis is another name for alcohol-induced fatty liver disease. It occurs when liver fat starts to accumulate. Alcohol abuse can prevent the liver from breaking down fats, leading to build-up. In heavy drinkers, alcoholic fatty liver disease is common. In fact, it's claimed that up to 90% of persons who consume large amounts of alcohol suffer from this illness and doesn’t often show any symptoms [3-5].

If drinking alcohol is stopped or reduced, alcoholic fatty liver disease can be reversed. However, if alcohol use persists, liver damage that is more severe in nature may result. Alcohol causes the liver inflammation known as alcoholic hepatitis. It can occur following binge drinking or long-term heavy drinking. The severity of alcoholic hepatitis might vary. Alcoholic hepatitis that is severe can be fatal [6,7]. Depending on how severe the problem is, alcoholic hepatitis requires different treatments. With nutrition support and alcohol abstinence, mild instances may improve. Hospitalisation, medicines, or even a liver transplant may be necessary in severe situations. The most severe type of alcohol-related liver disease is cirrhosis. It causes when good liver tissue is replaced by scar tissue as a result of on-going inflammation and injury brought on by alcohol. Scar tissue impairs blood flow and oxygen delivery to the liver cells, leading to their death. As a result, the liver loses its ability to function properly.

Alcohol-related cirrhosis is not reversible and can cause fatal liver failure. Treatment options are limited and mainly aim to prevent further damage and complications. Abstinence from alcohol is essential, as well as managing symptoms and complications with medications or procedures [8,9]. A liver transplant may be considered for some patients who meet certain criteria. Some diposomaniacs do not get alochol-related liver disease. However, some factors can increase the risk or severity of liver damage from alcohol. These include:

• some people may have inherited variations in genes that affect how they metabolize alcohol or respond to inflammation.

• women are more susceptible to alcohol-related liver damage than men because they have lower levels of enzymes that break down alcohol and higher levels of body fat that retain alcohol.

• malnutrition or obesity can worsen alcohol-related liver damage by affecting fat metabolism and antioxidant levels [10].

• viral hepatitis, autoimmune hepatitis, hemochromatosis, or non-alcoholic fatty liver disease can increase the risk or severity of alcohol-related liver damage.

Stopping or reducing alcohol use is the greatest method to stop or reverse alcohol-related liver damage. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines moderate drinking as up to one drink for women and up to two for men per day. One drink is equal to 12 ounces of beer, 5 ounces of wine, or 1.5 ounces of spirits.

Conclusion

Liver damage can manifest as alcoholic fatty liver disease, alcoholic hepatitis, or alcoholic cirrhosis. These conditions can impair the liver’s ability to carry out its vital functions and cause serious complications. The best way to prevent or reverse alcohol-related liver damage is to stop or reduce alcohol consumption. Other lifestyle changes such as eating a balanced diet, exercising regularly, quitting smoking, and getting vaccinated can also help improve liver health. More than three drinks per day for women and more than four for males is considered as over drinking.

References

1. Hussen N, Zhu L, Tetangco E, Ellison S. Hepatoptosis in a Patient with Alcoholic Hepatitis. Am J Gastroenterol. 2018;113(11):1581.

   [Cross Ref] [Google Scholar] [PubMed]

2. Ellison LM, Pinto PA, Kim F, Ong AM, Patriciu A, Stoianovici D, et al. Telerounding and patient satisfaction after surgery. J Am Coll Surg. 2004;199(4):523-530.

   [Cross Ref] [Google Scholar] [PubMed]

3. Boyle DK, Kochinda C. Enhancing collaborative communication of nurse and physician leadership in two intensive care units. J Nurs Adm. 2004;34(2):60-70.

   [Cross Ref] [Google Scholar] [PubMed]

4. Kalyesubula M, Mopuri R, Rosov A, Alon T, Edery N, et al. Hyperglycemia-stimulating diet induces liver steatosis in sheep. Sci Rep. 2020;10(1):12189.

   [Cross Ref] [Google Scholar] [PubMed]

5. Hashemi M. Heavy metal concentrations in bovine tissues (muscle, liver and kidney) and their relationship with heavy metal contents in consumed feed. Ecotoxicol Environ Saf. 2018;154:263-267.

   [Cross Ref] [Google Scholar] [PubMed]

6. Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immun. 2018;49(4):754-763.

   [Cross Ref] [Google Scholar] [PubMed]

7. Inokuchi-Shimizu S, Park EJ, Roh YS, Yang L, Zhang B, Song J, et al. TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. J Clin Invest. 2014;124(8):3566-35678.

   [Cross Ref] [Google Scholar] [PubMed] 

8. Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGASâ??STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501-521.

   [Cross Ref] [Google Scholar] [PubMed]

9. Takaki A, Kawai D, Yamamoto K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2013;14(10):20704-20728.

   [Cross Ref] [Google Scholar] [PubMed]

10. Wu J, Liu Q, Zhang X, Wu X, Zhao Y, Ren J. STING-dependent induction of lipid peroxidation mediates intestinal ischemia-reperfusion injury. Free Radic Biol Med. 2021;163:135-140.

    [Cross Ref] [Google Scholar] [PubMed]